Greater Philadelphia Life Sciences News: CHOP’s $1M CAR T Grant, Lilly Lehigh Valley Groundbreaking & More

Published · 8 min read · Greater Philadelphia
Greater Philadelphia Life Sciences News: CHOP’s $1M CAR T Grant, Lilly Lehigh Valley Groundbreaking & More

Greater Philadelphia – Regional Life Sciences Roundup – November 17, 2026

Capital is moving into early-stage research and clinical programs across Greater Philadelphia this week. At the same time, companies are dosing first patients, reporting trial data, and completing strategic deals that reshape their pipelines. The region’s academic and industry leadership is also shifting as institutions fill key roles and celebrate milestones.

Children’s Hospital of Philadelphia received a $1 million grant to test an mRNA-based CAR T therapy for a deadly childhood brain tumor. Eli Lilly broke ground on its $3.5 billion Lilly Lehigh Valley manufacturing site in Fogelsville, the largest life sciences investment in Pennsylvania history. Medicus Pharma closed $4.25 million in equity financings, with $750,000 from the CEO alone. Uniquity Bio reported statistically significant Phase 2 results for its TSLP antibody in eosinophilic esophagitis, with placebo-corrected histologic remission rates reaching 69 to 76 percent. Verismo Therapeutics licensed in vivo CAR T engineering technology from Stanford Medicine. MAXONA Pharmaceuticals dosed its first patient in a clinical trial for acute pain. Aclaris Therapeutics initiated a Phase 2b trial of modzatinib in lichen planus.

On the leadership side, Drexel University College of Medicine appointed Seena Ajit as interim chair of pharmacology and physiology, while Olimpia Meucci moved into a new University-wide role as Senior Vice President for Research, Innovation, and Strategic Partnerships. GSK won FDA approval for Nelkarmi (neladalkib) in previously treated ALK-positive non-small cell lung cancer. Viatris completed its acquisition of Pacira BioSciences. Integral Molecular celebrated 25 years as a cornerstone of Philadelphia’s biotech community.

The Howard Hughes Medical Institute is now supporting life science students from Community College of Philadelphia and eight other community colleges through its new Undergraduate Science Scholars Program. The Monell Science Entrepreneurship Program for Healthy Aging opened its interest list for the 2027 cohort.

Financial

Tracking the capital moving through Greater Philadelphia: funding rounds, M&A activity, and investment trends shaping Philadelphia, Southern New Jersey, and Delaware’s life sciences companies.

CHOP Receives $1 Million Grant to Test mRNA-Based CAR T-Cell Therapy for Deadly Childhood Brain Tumor | BioBuzz

Children’s Hospital of Philadelphia received a $1 million Accelerating Hope Award from Children’s Cancer Research Fund to launch an early-phase clinical trial for diffuse midline glioma, a deadly childhood brain tumor. The three-year grant will fund a trial testing a new form of CAR T-cell therapy made with mRNA technology, designed to be quicker, safer and less expensive than conventional approaches. Read More >

Ocugen and Celairis Therapeutics Enter into Exclusive License Agreement for OCU400 in Australia, New Zealand, and ASEAN

Ocugen and Celairis Therapeutics entered into an exclusive license agreement for OCU400 in Australia, New Zealand and ASEAN markets. The agreement grants Celairis rights to develop and commercialize the investigational gene therapy in those territories. Read More >

Medicus Pharma Announces Closing of $4.25 Million CEO-Led Equity Financings and $10.5 Million Debt Exchange – Medicus Pharma

Medicus Pharma closed 25 million in equity financings and a 5 million debt exchange, with the CEO and other insiders leading a 25 million private placement that included $750,000 from the CEO. The investment underscores management’s confidence in the company’s precision oncology strategy, anchored by its CD228V development program. Read More >

People

Who we’re buzzing about this week: the leadership moves, board appointments, and rising names shaping the region’s life sciences community.

People on the Move: Seena Ajit Named Interim Chair of Pharmacology and Physiology at Drexel University College of Medicine | BioBuzz

Drexel University College of Medicine appointed Seena Ajit, professor of pharmacology and physiology, as interim chair of its Department of Pharmacology and Physiology, effective November 16, 2026. Dr. Ajit has been a faculty member since 2009 and leads an NIH-funded lab studying the molecular mechanisms of pain and developing non-opioid treatments. Read More >

People on the Move: Olimpia Meucci Named Senior Vice President for Research, Innovation, and Strategic Partnerships at Drexel University | BioBuzz

Drexel University College of Medicine announced that Olimpia Meucci, professor and chair of its Department of Pharmacology and Physiology since 2016, is moving into a University-wide role as Senior Vice President for Research, Innovation, and Strategic Partnerships. During her tenure as chair, the department’s research expenditures increased fourfold and it secured $80 million in research awards. Read More >

Workforce

The hiring activity, team expansions, and talent trends driving growth across Philadelphia, New Jersey, and Delaware life sciences and biotech employers.

MSEP-HA 2027 Waiting List

The Monell Science Entrepreneurship Program for Healthy Aging, an NIH-funded training program, has opened its interest list for the 2027 cohort. The program brings together early-career scientists to explore sensory science, healthy aging, entrepreneurship and innovation through interactive workshops, mentorship and hands-on learning experiences focused on translating scientific discoveries into real-world solutions. Read More >

Howard Hughes Medical Institute supports life science students from Community College of Philadelphia and 8 other community colleges with launch of Undergraduate Science Scholars Program

The Howard Hughes Medical Institute launched its Undergraduate Science Scholars Program, supporting life science students from Community College of Philadelphia and eight other community colleges. The program aims to expand pathways into biomedical research and advanced STEM education for students from underrepresented backgrounds. Read More >

Who’s Hiring

TOP EMPLOYER
Globus Medical
172OPEN ROLES
FUNCTIONAL AREAS
•  Manufacturing & Technical Operations
•  Engineering, Automation & CQV
•  Project & Program Management
Open now: Integration Project Manager – Audubon, PA
See all roles ›
GSK
129OPEN ROLES
FUNCTIONAL AREAS
•  AI, Digital & Software Engineering
•  Clinical Development & Clinical Operations
•  Data, Bioinformatics & Computational Sciences
Open now: Director Global Regulatory Strategy, Oncology – Collegeville, PA
See all roles ›
ICON plc
122OPEN ROLES
FUNCTIONAL AREAS
•  Clinical Development & Clinical Operations
•  Project & Program Management
•  Medical Affairs & Scientific Communications
Open now: Global Head of Technical Regulatory & Quality (CMC, Quality & MDD) – Blue Bell, PA
See all roles ›
View all jobs on BioBuzz

Clinical + Commercial

The latest clinical trial progress, regulatory milestones, and commercial launches from companies advancing science from the lab to the market across Greater Philadelphia.

Verismo Therapeutics Licenses In Vivo CAR T Engineering Technology to Extend Its Novel Multi-Chain KIR-CAR Platform

Verismo Therapeutics licensed in vivo CAR T engineering technology from Stanford Medicine to extend its novel multi-chain KIR-CAR platform. The company intends to apply the technology to develop CAR T therapies that can be engineered directly inside the patient’s body, potentially eliminating the need for ex vivo cell manufacturing. Read More >

MAXONA PHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN MAX-001 CLINICAL TRIAL FOR ACUTE PAIN

MAXONA Pharmaceuticals announced that the first participant has been dosed in its MAX-001 clinical trial for acute pain. The trial is testing the company’s investigational non-opioid pain treatment, designed to provide an alternative to opioid-based therapies for managing acute pain. Read More >

Uniquity Bio Announces Statistically Significant and Clinically Meaningful Positive Topline Phase 2 Results for Solrikitug in Eosinophilic Esophagitis

Uniquity Bio reported statistically significant and clinically meaningful positive topline Phase 2 results for solrikitug in eosinophilic esophagitis. The investigational antibody targeting thymic stromal lymphopoietin achieved placebo-corrected histologic remission rates of 69 to 76 percent across all doses tested at week 24 and reduced dysphagia symptoms by 8 to 6 points. Read More >

Aclaris Therapeutics Initiates Phase 2b Trial of Modzatinib (ATI-2138) in Lichen Planus (LP) | Aclaris Therapeutics, Inc.

Aclaris Therapeutics initiated a Phase 2b trial of modzatinib (ATI-2138) in lichen planus, an inflammatory disease with no approved therapeutic options. The investigational therapy uses dual inhibition of ITK and JAK3, positioning it as a potential first-in-class mechanistically complete oral treatment for the condition. Read More >

Ecosystem

The partnerships, programs, and policy moves building Greater Philadelphia’s life sciences infrastructure, and the organizations driving it forward.

Integral Molecular Celebrates 25 Years of Advancing Drug Discovery as a Cornerstone of Philadelphia

Integral Molecular, a founding member of Philadelphia’s biotech community, celebrated 25 years of advancing drug discovery. The company has been a cornerstone of the region’s life sciences ecosystem since its founding in 2001, providing antibody discovery and characterization services to biotech and pharmaceutical companies worldwide. Read More >

Temple Health Welcomes Winn Awards to Fox Chase Cancer Center as Bristol Myers Squibb Foundation Renews Support Through 2030

Temple Health announced that Fox Chase Cancer Center will house the Robert A. Winn Excellence in Clinical Trials Award Program, as the Bristol Myers Squibb Foundation renewed its support for the program through 2030. The dual milestones mark a new chapter of national growth and impact for the program, which works to increase diversity in clinical trials. Read More >

150 Years In, Lilly Starts a New Chapter in the Lehigh Valley | BioBuzz

Eli Lilly and Company broke ground on Lilly Lehigh Valley, a 5 billion injectable medicine and device manufacturing site in Fogelsville, Pennsylvania. The facility will make next-generation injectable medicines for obesity and related diseases, bringing more than 850 permanent roles and about 2,000 construction jobs, with operations expected by 2031. Read More >

Other [Good] Reads

Editor’s picks from across the web: the stories, videos, and podcasts shaping the conversation in PHL biotech and life sciences this week.

How AI and Multiomics Are Improving Drug Safety and Efficacy Predictions | AstraZeneca

AstraZeneca is using artificial intelligence, multiomics and advanced cell models to improve drug safety and efficacy predictions earlier in development and with greater human relevance. The approach combines computational tools with biological data to identify potential risks and therapeutic effects before clinical trials begin. Read More >

King of Prussia Leads Region’s Suburban Life Sciences Market, New Report Finds, King of Prussia District

King of Prussia District released its 2026 Upper Merion Township/King of Prussia Life Sciences Report, highlighting the area’s concentration of life sciences companies, competitive real estate market and continued investment in advanced manufacturing. The report positions King of Prussia as a leader in Greater Philadelphia’s suburban life sciences market. Read More >

When Cancer Care Advances, Education Must Advance Too

Jazz Pharmaceuticals published a perspective on the need for education to advance alongside cancer care, as personalized and complex treatment options expand. The piece emphasizes that scientific progress only makes a difference when it reaches the people who need it, through meaningful information and timely support. Read More >

On the Calendar

A few of the upcoming events, conferences, and networking opportunities across Greater Philadelphia’s life sciences ecosystem that you don’t want to miss.

Advances in Microbiome Research: Host Communities to the Global Environment

Tuesday, December 1 · 4:30 PM–6:30 PM · Philadelphia, PA

Hosted by PennCHOP Microbiome Program | Register Now >

2026 BioNJ Inspiring STEM Conference

Friday, December 4 · 8:30 AM–2:45 PM · Plainsboro, NJ

Hosted by BioNJ | Register Now >

IS: Life Sciences

Thursday, December 10 · 8:30 AM–6:30 PM · The Innovation Space, Wilmington, DE

Hosted by The Innovation Space | Register Now >

See all events on BioBuzz

Did we miss something!? Drop us a line →

Stay connected to Greater Philadelphia’s life sciences.

Explore companies →   Browse jobs →   See events →   Read more →

Get Connected →